Sanofi to build $925M vaccine manufacturing facility in Toronto, Canada
Sanofi announced an investment of approximately CAD 925 million to build a new vaccine manufacturing facility at its existing site in Toronto, Canada. The facility will produce FLUZONE High-Dose Quadrivalent influenza vaccine and strengthen pandemic preparedness.
Value
$740.0M (925.0M CAD)
ProductsFLUZONE High-Dose Quadrivalent influenza vaccine
“Sanofi today announced an investment of more than €600 million in a new vaccine manufacturing facility at its existing site in Toronto, Canada.”sanofi.com
- 3 sources
- sanofi.comSanofi to build new facility in Canada to increase global availability of high-dose influenza vaccineMar 31, 2021
- sanoficanada.mediaroom.comSanofi to build new manufacturing facility in Toronto to strengthen domestic pandemic preparedness and increase global supply of high-dose influenza vaccine - Mar 31, 2021Mar 31, 2021
- bioprocessintl.comSanofi to build $700m flu vaccine plant - BioProcess InsiderDan StantonApr 1, 2021
Summarized from public sources; check the original articles before acting on it.
ENDATA